Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2005
09/21/2005EP1073446A4 Skin whitening composition
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005CN1671856A Novel physiologically active substances
09/21/2005CN1671837A Neutralizing human anti-IGFR antibody
09/21/2005CN1671745A Polysaccharide of echinacea angustifolia
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671713A Novel derivative of flavone c-glycoside and composition containing the same
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671405A Antipyrotic and method of manufacturing the same
09/21/2005CN1671404A Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/21/2005CN1671351A NSAID-containing topical formulations that demonstrate chemopreventive activity
09/21/2005CN1671287A Antimicrobial envelopes
09/21/2005CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1669583A 人参胶原蛋白 Ginseng Collagen
09/21/2005CN1669579A Compound mulberry hemp pill
09/21/2005CN1669569A Medicine for dispelling tinea
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219549C Skin-permeated absorption-promoting agent and cosmetics thereof
09/21/2005CN1219540C Chinese medicine for treating leukoderma and the preparation process of the tablets
09/21/2005CN1219531C A medicine for treating bed-sore and method for preparing same
09/21/2005CN1219527C Ointment for curing acne and its preparation method
09/21/2005CN1219521C A scar-removing acne-controlling formulation and preparation method
09/21/2005CN1219520C External preparations for treating dermatitis
09/21/2005CN1219519C Exterior used preparation for treating skin trauma
09/21/2005CN1219502C Chinese herbal medicine composition for eliminating foot foul
09/20/2005US6946543 Truncated EGF receptor
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946478 Compounds
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946436 Oil in water emulsions; mixture containing electrolyte, polyglycerol fatty acid ester, acrylic acid-alkyl methacrylate copolymer
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
09/20/2005US6946120 For therapy of hair loss
09/20/2005CA2304976C Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
09/20/2005CA2258891C Anticonvulsant derivatives useful in treating psoriasis
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/20/2005CA2189882C Papillomavirus vaccines
09/15/2005WO2005085241A1 Thiazole derivative
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085201A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005084702A1 Agent for preventing and treating organ fibrosis
09/15/2005WO2005084613A1 Skin preparation for external use
09/15/2005WO2004094472A3 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
09/15/2005WO2004056307A3 Disease treatment via antimicrobial peptide inhibitors
09/15/2005WO2004018465A9 Benzonaphthyridines with pde 3/4 inhibiting activity
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005US20050203181 Acyloxymethyl esters of C6-14 alkane-dicarboxylic acids, higher absorbtion of esters; does not induce bacterial resistance
09/15/2005US20050203158 Substituted benzimidazole compounds
09/15/2005US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203073 Method of treating inflammatory conditions with progesterone or progesterone analogs
09/15/2005US20050203068 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/15/2005US20050202411 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
09/15/2005US20050202410 Precise efficacy assay methods for active agents inlcluding chemotherapeutic agents
09/15/2005US20050202056 Swellable clay and lipases, esterases, ureases, or proteases
09/15/2005US20050202055 Retinoid of 4-(2,4-bistrimethylsilyphenylcarboxamide)benzoic acid or 4-[(5, 6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid; non irritanting
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050201996 Administering a probiotic to a household pet; contact dermatitis, actinic dermatitis, dermatitis caused by microbial infection, eczema and rosacea
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201955 Use of compatible solutes for inhibiting the release of ceramides
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574503A1 Novel 2,4-diamino-1,3,5-triazine derivative
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574207A1 Cosmetic use of viscous compositions containing carbon dioxide
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572934A2 Follistatin domain containing proteins
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572684A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572683A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 1065